On June 12, 2025, Tonix Pharmaceuticals appointed James Hunter to its Board of Directors, a decision announced via press release on June 13, 2025; he received 7,740 stock options with an exercise price of $34.54.
AI Assistant
TONIX PHARMACEUTICALS HOLDING CORP
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.